About us

Our company provides:

         - Regular supply of diagnostic kits and reagents for molecular diagnostics and research

         - Competent customer technical support

         -  Regular  release of newly developed products

         - we focus on development of test systems for molecular genetic diagnostics of cancer in order to assess the prognosis of    disease and the effectiveness of therapy.

 We offer Kits for:

         - study of genetic factors associated with the likelihood of ovarian cancer and breast cancer development

         - analysis of genetic factors that determine the course and prognosis of acute leukemia

         - analysis of  molecular markers that determine sensitivity to therapy ( for lung cancer and chronic myeloid leukemia)

         - assessment of minimal/mesuarble residual disease (MRD)  in acute and chronic myeloid leukemia

         - assessment of  donor cells engraftment - donor chimerism (during hematopoietic stem cell transplantation). This system    

            can also be used in the investigation of the kinship existence

          - the developed Kits are adapted for use with a capillary sequencer and the devices with the detection of the amplification  

            products in real-time, with respect to most available diagnostic laboratories now quite common.

 Our advantages

          - we adapt the Kits for any equipment (fluorescent Real-time PCR amplifiers, Sanger sequencers)       - ability to conduct training for working with the test systems, including on-site at the customer's laboratory     - possible development of a custom test system

Main Activity 

        - developing, manufacturing and distribution of reagents for diagnostics & Life Science

        - marketing and promotion of the products from the company portfolio

        - customer training and support

Company Philosophy

         We do not simply develop and sale the Kits  - we support the implementation of new tests and accompanying methodology with results in focus.

EN / FI